Hansa Biopharma AB (publ) (STO:HNSA)

Hansa Biopharma AB Revenue

Hansa Biopharma AB had revenue of 34.57M SEK in the quarter ending March 31, 2026, a decrease of -47.90%. This brings the company's revenue in the last twelve months to 190.49M, up 4.84% year-over-year. In the year 2025, Hansa Biopharma AB had annual revenue of 222.27M with 29.74% growth.

• Revenue (ttm): 190.49M
• Revenue Growth: +4.84%
• P/S Ratio: 17.88
• Revenue / Employee: 1.56M
• Employees: 122
• Market Cap: 3.40B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	222.27M	50.95M	29.74%
Dec 31, 2024	171.32M	37.22M	27.76%
Dec 31, 2023	134.09M	-20.43M	-13.22%
Dec 31, 2022	154.53M	120.65M	356.12%
Dec 31, 2021	33.88M	27.78M	455.56%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 22, 2026

Data Sources Report a data error